相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Design, synthesis, anti-cancer evaluation and binding mode studies of benzimidazole/benzoxazole linked β-carboline derivatives
Reddymasu Sireesha et al.
JOURNAL OF MOLECULAR STRUCTURE (2021)
Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes
Mohammed T-E Maghraby et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
A step-by-step synthesis of triazole-benzimidazole-chalcone hybrids: Anticancer activity in human cells+
Amar Djemoui et al.
JOURNAL OF MOLECULAR STRUCTURE (2020)
A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy
Adileh Ayati et al.
BIOORGANIC CHEMISTRY (2020)
Design, synthesis, biological evaluation, QSAR analysis and molecular modelling of new thiazol-benzimidazoles as EGFR inhibitors
Aladdin M. Srour et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Drug library screen reveals benzimidazole derivatives as selective cytotoxic agents for KRAS-mutant lung cancer
Iwao Shimomura et al.
CANCER LETTERS (2019)
Design, synthesis and docking studies of benzimidazole derivatives as potential EGFR inhibitors
Ismail Celik et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Osimertinib confers potent binding affinity to EGFR kinase domain duplication
Rui Jin et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Efficacy of Afatinib and Lapatinib Against HER2 Gene-amplified Trastuzumab-sensitive and-resistant Human Gastric Cancer Cells
Susumu Nakata et al.
ANTICANCER RESEARCH (2019)
Efficacy of long-term oral telmisartan treatment in cats with hypertension: Results of a prospective European clinical trial
Tony M. Glaus et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2019)
Azole-hydrazone derivatives: Design, synthesis, in vitro biological evaluation, dual EGFR/HER2 inhibitory activity, cell cycle analysis and molecular docking study as anticancer agents
Madlen B. Labib et al.
BIOORGANIC CHEMISTRY (2018)
Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors
Md. Jawaid Akhtar et al.
BIOORGANIC CHEMISTRY (2018)
One-pot synthesis of benzimidazole using DMF as a multitasking reagent in presence CuFe2O4 as catalyst
Kalidas B. Rasal et al.
CATALYSIS TODAY (2018)
Novel aminopyrimidinyl benzimidazoles as potentially antimicrobial agents: Design, synthesis and biological evaluation
Han-Bo Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Structural insights into drug development strategy targeting EGFR T790M/C797S
Su-Jie Zhu et al.
Oncotarget (2018)
Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer
Nele Van Der Steen et al.
CANCER DRUG RESISTANCE (2018)
Determinants of Gefitinib toxicity in advanced non-small cell lung cancer (NSCLC): a pharmacogenomic study of metabolic enzymes and transporters
Y. Ma et al.
PHARMACOGENOMICS JOURNAL (2017)
Design, synthesis, docking and QSAR study of substituted benzimidazole linked oxadiazole as cytotoxic agents, EGFR and erbB2 receptor inhibitors
Md Jawaid Akhtar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
Ping Wee et al.
CANCERS (2017)
Synthesis and antifungal activities of some benzimidazolyl-chalcones, analogues of chlormidazole
Sissouma Drissa et al.
African Journal of Pharmacy and Pharmacology (2016)
Design, synthesis and molecular modeling studies of few chalcone analogues of benzimidazole for epidermal growth factor receptor inhibitor in search of useful anticancer agent
Santosh S. Chhajed et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2016)
Discovery of (R,E)-N-(7-Chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide (EGF816), a Novel, Potent, and WT Sparing Covalent Inhibitor of Oncogenic (L858R, ex19del) and Resistant (T790M) EGFR Mutants for the Treatment of EGFR Mutant Non-Small-Cell Lung Cancers
Gerald Lelais et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Identification of gefitinib off-targets using a structure-based systems biology approach; their validation with reverse docking and retrospective data mining
Nidhi Verma et al.
SCIENTIFIC REPORTS (2016)
A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells
B. Chu et al.
CELL DEATH & DISEASE (2015)
Evaluation of antiulcer activity of indole-3-carbinol and/or omeprazole on aspirin-induced gastric ulcer in rats
Nashwa A. El-Shinnawy et al.
TOXICOLOGY AND INDUSTRIAL HEALTH (2014)
Network Understanding of Herb Medicine via Rapid Identification of Ingredient-Target Interactions
Hai-Ping Zhang et al.
SCIENTIFIC REPORTS (2014)
Synthesis and Antibacterial Evaluation of Some Novel Imidazole and Benzimidazole Sulfonamides
Nassir N. Al-Mohammed et al.
MOLECULES (2013)
Phosphoproteomic analysis identifies activated MET-axis PI3K/AKT and MAPK/ERK in lapatinib-resistant cancer cell line
Yong Yook Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2013)
Synthesis, biological evaluation and SAR studies of benzimidazole derivatives as H1-antihistamine agents
Xiao Jian Wang et al.
CHINESE CHEMICAL LETTERS (2012)
Synthesis, characterization and antimicrobial studies of some new quinoline incorporated benzimidazole derivatives
B. Garudachari et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker
Flavio Solca et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors
Yunqi Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Ligand-based receptor tyrosine kinase partial agonists: new paradigm for cancer drug discovery?
David J. Riese
EXPERT OPINION ON DRUG DISCOVERY (2011)
Phase I Study of Sunitinib and Erlotinib in Advanced Nonsquamous Non-small Cell Lung Cancer
Shannon E. O'Mahar et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Quantitative understanding of cell signaling: the importance of membrane organization
Krishnan Radhakrishnan et al.
CURRENT OPINION IN BIOTECHNOLOGY (2010)
Docking to Erlotinib Off-Targets Leads to Inhibitors of Lung Cancer Cell Proliferation with Suitable in Vitro Pharmacokinetics
Liwei Li et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
Induced-fit docking studies of the active and inactive states of protein tyrosine kinases
Haizhen Zhong et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2009)
Structure-based view of epidermal growth factor receptor regulation
Kathryn M. Ferguson
ANNUAL REVIEW OF BIOPHYSICS (2008)
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
Cai-Hong Yun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Structure and dynamics of the epidermal growth factor receptor C-terminal phosphorylation domain
NY Lee et al.
PROTEIN SCIENCE (2006)
Evaluation of docking performance: Comparative data on docking algorithms
M Kontoyianni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
分享论文
